Showing results (131-140 of 406) with videos related to
Sort By:
Pageof 41
Neurology|September 28, 2005
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosisDavid J Rog, Turo J Nurmikko, Tim Friede, et al.Journal of Biopharmaceutical Statistics|April 5, 2014
A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpointsCornelia Ursula Kunz, Tim Friede, Nicholas Parsons, et al.Spine|November 8, 2012
Systematic review of randomized controlled trials of clinical prediction rules for physical therapy in low back painShilpa Patel, Tim Friede, Robert Froud, et al.Drug Design, Development and Therapy|June 1, 2011
Development of oral immunomodulatory agents in the management of multiple sclerosisRichard Nicholas, Paolo Giannetti, Ali Alsanousi, et al.The Clinical Journal of Pain|June 19, 2007
Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosisDavid J Rog, Turo J Nurmikko, Tim Friede, et al.Pharmaceutical Statistics|May 3, 2014
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome dataCornelia Ursula Kunz, Tim Friede, Nick Parsons, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trialsRichard S Nicholas, Erika Han, Joel Raffel, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|December 3, 2020
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systemsAnn-Kathrin Frenz, Christiane Ahlers, Vita Beckert, et al.Statistics in Medicine|October 17, 2014
Spline-based procedures for dose-finding studies with active controlHans-Joachim Helms, Norbert Benda, Jörg Zinserling, et al.Current Medical Research and Opinion|November 16, 2007
Rivastigmine exposure provided by a transdermal patch versus capsulesFrançois Mercier, Gilbert Lefèvre, Hsun-Lun Aaron Huang, et al.Pageof 41